Jardiance 25 mg (Tablet)

Unit Price: ৳ 84.00 (9 x 10: ৳ 7,560.00)
Strip Price: ৳ 840.00

Medicine Details

Category Details
Generic Empagliflozin
Company Boehringer ingelheim
Also available as
Jardiance 10 mg tablet

Title

  • Jardiance 25 mg Tablet

Categories

  • Medicine
  • Diabetes Management
  • Cardiovascular Health
  • Pharmacology
  • Therapeutic Class: SGLT2 Inhibitor

Description

  • Jardiance is indicated as an adjunct to diet and exercise for type 2 diabetes mellitus
  • It is also used to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
  • Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor, reducing renal absorption and lowering the renal threshold for glucose
  • The recommended dose is 10 mg once daily, may be increased to 25 mg once daily in patients tolerating it

Indications

  • Improving glycemic control in adults with type 2 diabetes mellitus
  • Reducing the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease

Pharmacology

  • SGLT-2 inhibitor
  • Reduces renal absorption of glucose
  • Lowers the renal threshold for glucose
  • Contributes to reducing hyperglycemia
  • Assists weight loss
  • Reduces blood pressure

Dosage & Administration

Recommended dose of Empagliflozin is 10 mg once daily, may be increased to 25 mg once daily in patients tolerating it. Correcting volume depletion prior to initiation is recommended.

Interactions

  • Diuretics
  • Insulin or Insulin Secretagogues
  • Positive Urine Glucose Test
  • Interference with 1,5-anhydroglucitol (1,5-AG) Assay

Contraindications

  • History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients
  • Severe renal impairment
  • End-stage renal disease
  • Dialysis

Side Effects

  • Urinary tract infections
  • Female genital mycotic infections
  • Dehydration
  • Hypotension
  • Weakness
  • Dizziness
  • Increased thirstiness

Pregnancy & Lactation

  • No adequate and well-controlled studies in pregnant women
  • Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus
  • Not recommended when breastfeeding

Precautions & Warnings

  • Assessment of renal function recommended prior to initiation
  • Jardiance should not be initiated in patients with an eGFR less than 45 ml/min/1.73 m²
  • No dose adjustment needed for patients with an eGFR greater than or equal to 45 ml/min/1.73 m²

Overdose Effects

Supportive measures should be employed in the event of an overdose with Jardiance.

Therapeutic Class

  • Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Chemical Structure

  • Molecular Formula: C23H27ClO7
  • Chemical Structure Image URL: https://medex.com.bd/storage/res/g-res-1275-empagliflozin-chemical-structure-Z3X0mrA6UvgM682Jgp8K.svg

Commonly Asked Questions

  • What is Jardiance 25 mg Tablet?
  • What is Jardiance 25 mg Tablet used for?
  • Are there any pregnancy warnings?
  • Are there any breast-feeding warnings?
  • Does this affect kidney function?
  • Does this affect liver function?
  • Quick Tips

Additional Information

  • Usable as monotherapy or in combination with other diabetes medicines
  • May cause dehydration and hypoglycemia
  • May lead to genital fungal and urinary tract infections
  • Regular blood sugar monitoring recommended
  • Consult doctor for specific symptoms

Related Brands